Nitric oxide donors for patients undergoing IVF. A prospective, double-blind, randomized, placebo-controlled trial.

@article{Ohl2002NitricOD,
  title={Nitric oxide donors for patients undergoing IVF. A prospective, double-blind, randomized, placebo-controlled trial.},
  author={Jeanine Ohl and Catherine Lef{\`e}bvre-Maunoury and Christiane Wittemer and Gabriel Nisand and Marie-Christine Laurent and Pascale Hoffmann},
  journal={Human reproduction},
  year={2002},
  volume={17 10},
  pages={
          2615-20
        }
}
  • Jeanine Ohl, Catherine Lefèbvre-Maunoury, +3 authors Pascale Hoffmann
  • Published in Human reproduction 2002
  • Medicine
  • BACKGROUND Nitric oxide (NO) is involved in local control of the uterine cycle and in preparation of the uterus for pregnancy. NO donors, acting as vasodilating agents, may therefore have possible therapeutic uses, for example they may be of benefit to patients with a history of implantation failure. In a prospective, comparative, randomized, placebo-controlled study, we assessed the efficacy of nitroglycerin (NTG) administered to 138 IVF patients with a history of implantation failure… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Figures, Tables, and Topics from this paper.

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 18 CITATIONS

    Evolutionary interactions between diabetes and development.

    VIEW 2 EXCERPTS
    CITES BACKGROUND

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 32 REFERENCES

    Nitric oxide donors in pregnancy: fetomaternal hemodynamic effects induced in mild pre-eclampsia and threatened preterm labor.

    VIEW 3 EXCERPTS
    HIGHLY INFLUENTIAL